Natural killer cells show their cancer-fighting worthNatural killer (NK) cells from umbilical-cord blood show promise as a potentially effective and less side-effect-prone alternative to T-cell therapies for blood cancer treatment.
Studying use of patients' own reprogrammed cells to attack cancer as alternative to more chemoCAR-T therapy is a promising type of immunotherapy for blood cancer patients.Research is underway to determine if CAR-T therapy could be more beneficial when administered earlier in the treatment process.
Natural killer cells show their cancer-fighting worthNatural killer (NK) cells from umbilical-cord blood show promise as a potentially effective and less side-effect-prone alternative to T-cell therapies for blood cancer treatment.
Studying use of patients' own reprogrammed cells to attack cancer as alternative to more chemoCAR-T therapy is a promising type of immunotherapy for blood cancer patients.Research is underway to determine if CAR-T therapy could be more beneficial when administered earlier in the treatment process.
Novel teamwork, promising results for glioblastoma treatment - Harvard GazetteCollaboration is essential in the success of medical research projects.Academic medicine plays a crucial role in bridging the gap between lab research and clinical trials.
Cutting-edge CAR-T cancer therapy is now made in India - at one-tenth the costIndian biotech company produces affordable CAR-T therapyPromise of CAR-T therapy in treating cancer and autoimmune diseases
Daily briefing: The last universal common ancestor lived around 4.2 billion years agoThe shared forebearer of all life likely consumed carbon dioxide and hydrogen.
This kids' brain cancer is incurable - but immune therapy holds promiseCAR-T therapy shows promise in treating deadly brain tumors in children.
From the wheelchair to the bicycle: CAR-Ts achieve spectacular remissions against autoimmune diseasesSinger Celine Dion opened up about her battle with stiff person syndrome, a rare autoimmune disease. An experimental treatment showed promise for those struggling with the condition.